SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001356576-21-000087
Filing Date
2021-10-28
Accepted
2021-10-27 18:21:56
Documents
14
Period of Report
2021-10-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K supn-20211027.htm   iXBRL 8-K 34368
2 EX-99.1 ex99110-27x2021.htm EX-99.1 10170
6 image_0.jpg GRAPHIC 5496
  Complete submission text file 0001356576-21-000087.txt   190131

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT supn-20211027.xsd EX-101.SCH 1915
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT supn-20211027_lab.xml EX-101.LAB 24136
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT supn-20211027_pre.xml EX-101.PRE 12520
7 EXTRACTED XBRL INSTANCE DOCUMENT supn-20211027_htm.xml XML 10822
Mailing Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850
Business Address 9715 KEY WEST AVENUE ROCKVILLE MD 20850 301-838-2500
SUPERNUS PHARMACEUTICALS, INC. (Filer) CIK: 0001356576 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35518 | Film No.: 211354419
SIC: 2834 Pharmaceutical Preparations